Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that the Light Study, a long-term research study of Contrave® (naltrexone SR/bupropion SR), a new, investigational drug being evaluated for weight loss, has begun enrolling patients at clinical sites throughout the United States. The Light Study is designed to assess the cardiovascular health outcomes of Contrave.
Nearly 93 million Americans are affected by obesity, and that number is predicted to increase to 120 million Americans within the next five years. More than one-third of adults in the United States are affected by obesity. Obesity increases the risk of heart disease, type 2 diabetes, some types of cancer, sleep apnea, and a variety of other conditions. Medical research suggests that losing just five percent of your body weight can significantly improve your health and reduce the risk of complications from type 2 diabetes and heart disease.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56480-lightstudy
St. Jude Children’s Research Hospital is launching a new series of public service announcements (PSAs) to help raise awareness and deepen the understanding of the hospital’s lifesaving mission through real St. Jude heroes – its patients and families. St. Jude has not produced national PSAs since 2003 and timed this new multichannel campaign to coincide with the hospital’s 50th anniversary.
The PSAs share St. Jude moments through patients and families like 10-year-old Angiel. Angiel and her mom Damaris were planning a trip to Africa for a family reunion when she was diagnosed with osteosarcoma, a type of bone cancer that produced tumors in both of Angiel’s legs. Today, thanks to St. Jude doctors, Angiel can still look forward to visiting family in a foreign land one day. Angiel’s story is just one of several patients featured in the PSAs.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/stjude/46749/
NESTLÉ JUICY JUICE, Feeding America® and celebrity mom and anti-hunger advocate Samantha Harris celebrated the kickoff of the JUICY JUICE Fruit for All Project at the Los Angeles Regional Food Bank on May 31, 2012. The program is designed to help alleviate summertime childhood hunger by delivering up to 35 million pieces of fresh fruit to children and families at risk of hunger nationwide. Today through August 31, one piece of fruit will be provided to hungry kids and their families each time JUICY JUICE is purchased*.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56081-nestle-juicy-juice-feeding-america-samantha-harris-childhood-hunger
*Donation promotion runs from June 1, 2012 to August 31, 2012 and includes all JUICY JUICE® retail pack sizes. Excludes any JUICYJUICE® product sold at foodservice outlets. During the promotion period, Nestlé shall donate to Feeding America the funds needed to deliver up to 35,000,000 pieces of fruit based on in-store sales and completion of online challenges at FruitForAllProject.com. Maximum donation is $420,000.
Boehringer Ingelheim Pharmaceuticals, Inc. and CancerCare® today announced the launch of My Cancer Circle™ (www.MyCancerCircle.net), a free, private, customizable online tool that enables caregivers of people facing cancer to organize and coordinate a circle of family members and friends to provide practical and emotional support. MyCancerCircle.net will provide caregivers of people facing cancer a simple, effective answer to a question they are asked constantly, “What can we do to help?”
To view Multimedia News Release, go to http://www.multivu.com/mnr/56339-boehringer-ingelheim-cancercare-my-cancer-circle-online-tool-caregivers
Janssen Healthcare Innovation, a team within Janssen Research & Development, LLC (Janssen), today announced Discharge Decision Support System (D2S2) is the winner of the crowdsourcing-inspired Janssen Connected Care Challenge and the $100,000 prize. D2S2 is a discharge decision support system that uses a proprietary algorithm to assemble and score key data upon hospital admission in order to identify patients who should be referred to post-acute care services to reduce the risk of 30-day readmissions.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56342-discharge-decision-support-system-janssen-connected-care-challenge
The controversy surrounding tanning continues to mount. More and more young women are being diagnosed with melanoma and the incidence of painful sunburns from tanning beds is becoming more frequent. These health hazards, coupled with the recent exposé of New Jersey “tanning mom,” have led to a recent backlash against the dark bronze look.
May is Melanoma Awareness month, and now more than ever, people across the country, from teens to fashion and beauty icons, are taking a stand against the deep suntan and looking for ways to get a gorgeous glow without tanning. Jergens® offers the ultimate solution to get a healthy-looking glow and keep your skin safe with Natural Glow & Protect Daily Moisturizer.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56364-jergens-natural-glow-and-protect-daily-moisturizer-ban-the-tan
Fluke Corporation introduces the Fluke® 805 Vibration Meter, a portable multifunction vibration screening tool that provides quantifiable information on the bearing and overall health of motors and other rotating equipment. The Fluke 805 is ideal for frontline mechanical troubleshooting teams that need reliable and repeatable measurements of rotating equipment to make imperative go/no-go maintenance decisions.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56349-new-fluke-805-vibration-meter-redefines-vibration-screening
A landmark summer research study has unveiled a vital component of wellness and happiness…vacations. The survey, “The Takeaways from Getaways,” commissioned by the Las Vegas Convention and Visitors Authority, draws attention to the serious physical and emotional implications of stress and feeling over worked, and the inextricable link between vacation and personal wellness and happiness.
The research revealed surprisingly that more than 9 out of 10 Americans reported feeling happier after taking a vacation. And seventy-seven percent (77%) believed that their overall health improves after a getaway. Even so, more than half of Americans admitted that doctors should be able to prescribe vacations as a curative and therapeutic option for stress-related maladies.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56160-the-takeaways-from-getaways-visit-las-vegas-lvcva
A pill designed to zero in on abnormal genes that drive specific cancers has produced encouraging early results in children with an uncommon but aggressive type of lymphoma, as well as in children with a rare form of neuroblastoma.
A phase 1 clinical trial of the drug crizotinib achieved remissions, with minimal side effects, for 10 of the children participating in a clinical study carried out by the multicenter Children’s Oncology Group (COG). The results were “an exciting proof-of-principle” for the targeted treatment, said the study leader, Yaël P. Mossé, M.D., a pediatric oncologist at The Children’s Hospital of Philadelphia.
“We are entering a new era of cancer therapy, in which we use knowledge of basic biology to design very specific drugs that target cancer cells with potentially less side effects on healthy tissue,” said Mossé. “In addition, as we concentrate on targets in molecular pathways, we move away from an exclusive focus on one form of cancer to customizing treatments according to biological activity. Abnormal ALK activity occurs in subtypes of neuroblastoma and subtypes of lymphoma, so identifying ALK activity in individual patients may enable us to provide the most effective care.”
To view Multimedia News Release, go to http://www.multivu.com/mnr/50776-childrens-hospital-philadelphia-lymphoma-neuroblastoma-oncology-gene-trial
In collaboration with the National Institutes of Health (NIH), Banner Alzheimer’s Institute (BAI), University of Antioquia in Colombia and Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announce the first-ever prevention trial in cognitively healthy individuals who are destined to develop Alzheimer’s disease because of their genetic history. This groundbreaking study—the first to investigate whether an anti-amyloid treatment can stave off the disease—will span two countries and help launch a new era of prevention research in the urgent fight against Alzheimer’s.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56128-banner-alzheimer-s-institute-genentech-nih-prevention-trial-genetics
The National Bone Health Alliance (NBHA), a public-private partnership with 42 member organizations, is urging a simple solution to a big problem: if it’s 50+ fracture, request a test. This is the call-to-action for the NBHA’s new public and healthcare professional education campaign – 2Million2Many (www.2Million2Many.org).
The campaign reflects the two million bone breaks that occur in the U.S. each year that are caused by osteoporosis and urges the public and healthcare professionals alike to take action and request a test for osteoporosis when someone age 50 or older breaks a bone. Despite the fact that 50 percent of osteoporosis-related repeat fractures can be prevented with existing treatments, only two in 10 initial bone breaks get a follow-up test or treatment for osteoporosis.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56192-national-bone-health-alliance-nbha-prevent-osteoporosis-2million2many
Kohl’s Department Stores (NYSE: KSS) announced today that in celebration of life, survival, and a “Wish for a World with Less Breast Cancer and More Birthdays,” Kohl’s threw a “One Wish” Birthday Bash at the 2012 American Cancer Society Making Strides Against Breast Cancer® walk, May 5, 2012, on Milwaukee’s lakefront. Decorated with nearly 8,000 pink cake pops, balloons and giant birthday candles, the celebration represents the company’s greater commitment to the fight against breast cancer. More than 3,000 Kohl’s associates, friends and family took part in the walk.
To view Multimedia News Release, go to http://www.multivu.com/mnr/55012-kohl-s-one-wish-birthday-2012-making-strides-against-breast-cancer-walk
